Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval
Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval Medical Device Network
Regulatory Approvals
FDA clears Roche and Eli Lilly’s Alzheimer’s blood test for primary and specialty care
FDA clears Roche and Eli Lilly's Alzheimer's blood test for primary and specialty care qz.com
FDA approves a new blood test to detect signs of Alzheimer’s
FDA approves a new blood test to detect signs of Alzheimer’s The Washington Post
FDA Clears Roche’s Single-Biomarker Elecsys pTau217 Blood Test for Alzheimer Disease
FDA Clears Roche's Single-Biomarker Elecsys pTau217 Blood Test for Alzheimer Disease NeurologyLive
Recon: FDA clears Roche, Lilly Alzheimer’s blood tests; Regenxbio gene therapy trial halted by FDA again
Recon: FDA clears Roche, Lilly Alzheimer’s blood tests; Regenxbio gene therapy trial halted by FDA again RAPS